{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:28Z","timestamp":1791337948235,"version":"4.3.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The treatment goal in congenital adrenal hyperplasia (CAH) is to replace glucocorticoids while avoiding androgen excess and iatrogenic Cushing's syndrome. However, there is no consensus on how to monitor disease control. Our main objectives were to evaluate hormonal circadian rhythms and use these profiles to identify optimal monitoring times and novel disease biomarkers in CAH adults on intermediate- and long-acting glucocorticoids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This was an observational, cross-sectional study at the National Institutes of Health Clinical Center in 16 patients with classic CAH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty-four-hour serum sampling for ACTH, 17-hydroxyprogesterone (17OHP), androstenedione (A<jats:sub>4<\/jats:sub>), androsterone, DHEA, testosterone, progesterone and 24-h urinary pdiol and 5\u03b2-pdiol was carried out. Bayesian spectral analysis and cosinor analysis were performed to detect circadian rhythmicity. The number of hours to minimal (<jats:italic>T<\/jats:italic><jats:sub>min<\/jats:sub>AC) and maximal (<jats:italic>T<\/jats:italic><jats:sub>max<\/jats:sub>AC) adrenocortical hormone levels after dose administration was calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A significant rhythm was confirmed for ACTH (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.95;<jats:italic>P<\/jats:italic>&lt;0.001), 17OHP (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.70;<jats:italic>P<\/jats:italic>=0.003), androstenedione (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.47;<jats:italic>P<\/jats:italic>=0.043), androsterone (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.80;<jats:italic>P<\/jats:italic>&lt;0.001), testosterone (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.47;<jats:italic>P<\/jats:italic>=0.042) and progesterone (<jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>, 0.64;<jats:italic>P<\/jats:italic>=0.006). The mean (<jats:sc>s.d.<\/jats:sc>)<jats:italic>T<\/jats:italic><jats:sub>min<\/jats:sub>AC and<jats:italic>T<\/jats:italic><jats:sub>max<\/jats:sub>AC for 17OHP and A<jats:sub>4<\/jats:sub>were: morning prednisone (4.3 (2.3) and 9.7 (3.5) h), evening prednisone (4.5 (2.0) and 10.3 (2.4) h), and daily dexamethasone (9.2 (3.5) and 16.4 (7.2) h). AUC<jats:sub>0\u201324 h<\/jats:sub>progesterone, androsterone and 24-h urine pdiol were significantly related to 17OHP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In CAH patients, adrenal androgens exhibit circadian rhythms influenced by glucocorticoid replacement. Measurement of adrenocortical hormones and interpretation of results should take into account the type of glucocorticoid and time of dose administration. Progesterone and backdoor metabolites may provide alternative disease biomarkers.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-15-0064","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T02:19:25Z","timestamp":1441419565000},"page":"727-737","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":46,"title":["Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers"],"prefix":"10.1093","volume":"173","author":[{"given":"Miguel","family":"Debono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Mallappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Gounden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini A","family":"Nella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Crutchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Backlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Soldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P","family":"Merke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2015102318231827000_173.6.727.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2631"},{"key":"2015102318231827000_173.6.727.2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-2-452"},{"key":"2015102318231827000_173.6.727.3","doi-asserted-by":"publisher","DOI":"10.1136\/adc.56.3.208"},{"key":"2015102318231827000_173.6.727.4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.63.6.617"},{"key":"2015102318231827000_173.6.727.5","doi-asserted-by":"crossref","unstructured":"Hughes IA Read GF . Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements. Hormone Research 1984 19 77\u201385. (doi:10.1159\/000179870).","DOI":"10.1159\/000179870"},{"key":"2015102318231827000_173.6.727.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1440"},{"key":"2015102318231827000_173.6.727.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66736-0"},{"key":"2015102318231827000_173.6.727.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.1200"},{"key":"2015102318231827000_173.6.727.9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561028"},{"key":"2015102318231827000_173.6.727.10","unstructured":"Fuqua JS Rotenstein D Lee PA . Duration of suppression of adrenal steroids after glucocorticoid administration. International Journal of Pediatric Endocrinology 2010 2010 712549. (doi:10.1186\/1687-9856-2010-712549)."},{"key":"2015102318231827000_173.6.727.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1997"},{"key":"2015102318231827000_173.6.727.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0319"},{"key":"2015102318231827000_173.6.727.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.03.034"},{"key":"2015102318231827000_173.6.727.14","unstructured":"Stolze BGV Gu J Soldin SJ . A408 Development and Validation of a High Performance Liquid Chromatography Tandem Mass Spectrometry 9 Steroid Panel using Minimal Sample Volume. AACC Annual meeting Abstracts 2014 S133."},{"key":"2015102318231827000_173.6.727.15","doi-asserted-by":"crossref","unstructured":"Hansen LK Nielsen FA Larsen J . Exploring fMRI data for periodic signal components. Artificial Intelligence in Medicine 2002 25 35\u201344. (doi:10.1016\/S0933-3657(02)00007-6).","DOI":"10.1016\/S0933-3657(02)00007-6"},{"key":"2015102318231827000_173.6.727.16","doi-asserted-by":"crossref","unstructured":"Bretthorst GL. Bayesian spectrum analysis and parameter estimation. Lecture Notes in Statistics. Berlin: Springer-Verlag, 1988","DOI":"10.1007\/978-1-4684-9399-3"},{"key":"2015102318231827000_173.6.727.17","doi-asserted-by":"crossref","unstructured":"Cornelissen G . Cosinor-based rhythmometry. Theoretical Biology & Medical Modelling 2014 11 16. (doi:10.1186\/1742-4682-11-16).","DOI":"10.1186\/1742-4682-11-16"},{"key":"2015102318231827000_173.6.727.18","unstructured":"Cugini P . Chronobiology: principles and methods. Annali dell'Istituto Superiore di Sanit\u00e0 1993 29 483\u2013500."},{"key":"2015102318231827000_173.6.727.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2102"},{"key":"2015102318231827000_173.6.727.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0917"},{"key":"2015102318231827000_173.6.727.21","doi-asserted-by":"crossref","unstructured":"Horrocks PM London DR . A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia. Clinical Endocrinology 1982 17 547\u2013556. (doi:10.1111\/j.1365-2265.1982.tb01613.x).","DOI":"10.1111\/j.1365-2265.1982.tb01613.x"},{"key":"2015102318231827000_173.6.727.22","unstructured":"Dauber A Feldman HA Majzoub JA . Nocturnal dexamethasone versus hydrocortisone for the treatment of children with congenital adrenal hyperplasia. International Journal of Pediatric Endocrinology 2010 2010 347636. (doi:10.1186\/1687-9856-2010-347636)."},{"key":"2015102318231827000_173.6.727.23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0865"},{"key":"2015102318231827000_173.6.727.24","unstructured":"Repchinsky C. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals 2008 Ottawa N Canadian pharmacists Association 2008 Corticosteroids pg 574 to 576"},{"key":"2015102318231827000_173.6.727.25","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-4-717"},{"key":"2015102318231827000_173.6.727.26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600640122"},{"key":"2015102318231827000_173.6.727.27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90233-9"},{"key":"2015102318231827000_173.6.727.28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.4679"},{"key":"2015102318231827000_173.6.727.29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.8.743"},{"key":"2015102318231827000_173.6.727.30","doi-asserted-by":"crossref","unstructured":"Rivkees SA . Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the \"growth toxic\" glucocorticoid. International Journal of Pediatric Endocrinology 2010 2010 569680.","DOI":"10.1155\/2010\/569680"},{"key":"2015102318231827000_173.6.727.31","doi-asserted-by":"crossref","unstructured":"Volkl TM Ohl L Rauh M Schofl C Dorr HG . Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research in Paediatrics 2011 76 400\u2013410. (doi:10.1159\/000333696).","DOI":"10.1159\/000333696"},{"key":"2015102318231827000_173.6.727.32","doi-asserted-by":"crossref","unstructured":"El-Maouche D Collier S Prasad M Reynolds JC Merke DP . Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinical Endocrinology 2015 82 330\u2013337. (doi:10.1111\/cen.12507).","DOI":"10.1111\/cen.12507"},{"key":"2015102318231827000_173.6.727.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011093431903"},{"key":"2015102318231827000_173.6.727.34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0692"},{"key":"2015102318231827000_173.6.727.35","unstructured":"Witchel SF Azziz R . Nonclassic congenital adrenal hyperplasia. International Journal of Pediatric Endocrinology 2010 2010 625105. (doi:10.1186\/1687-9856-2010-625105)."},{"key":"2015102318231827000_173.6.727.36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0454"},{"key":"2015102318231827000_173.6.727.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2004.09.004"},{"key":"2015102318231827000_173.6.727.38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1331751"},{"key":"2015102318231827000_173.6.727.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1258"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/6\/727.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/6\/727.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:32:26Z","timestamp":1676392346000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/173\/6\/727\/6663620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":39,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0064","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}